News and updatesCheck out what is going on

See all of the updates and news from Clinicalconsulting!
https://clinicalconsulting.pl/wp-content/uploads/2021/01/3d-render-of-a-medical-background-with-virus-cells-1-1280x640.jpg

Wrocław Medical University together with Clinical Consulting has developed the first nationwide clinical trial program in Poland, which gives hope to avoid or reduce severe pulmonary complications during coronavirus infection. 400 patients are planned to be recruited in the study. The study is coordinated by a team of experts from Clinical Consulting and infectious diseases...

https://clinicalconsulting.pl/wp-content/uploads/2021/01/new.jpg

Article comes from https://www.prnewswire.com   SAN DIEGO, May 14, 2018 /PRNewswire/ — Immunicom, Inc., a medical technology company developing revolutionary non-pharmaceutical approaches for treating cancer and autoimmune diseases, has received Breakthrough Device designation from the U.S. Food and Drug Administration (FDA) for its Immunopheresis™ therapy, which is based on a proprietary technology that selectively removes...

https://clinicalconsulting.pl/wp-content/uploads/2021/01/9fdfd7_c8c896b476c94dc9b9420b98a43f47e3_mv2.jpg

Polish Ministry of Health, Polish Development Fund and Patient Rights Commissioner have started a campaign to raise patients’ awareness of clinical trials called ‘Patient in Clinical Research’.   Clinical trials depend on the patients willingness to participate. When a patient is being informed by a doctor for the first time about clinical trial, there is...

https://clinicalconsulting.pl/wp-content/uploads/2021/01/pexels-sora-shimazaki-5668882-1280x640.jpg

Currently, while submitting CTA, Sponsor has to attach signed agreements with all Investigators and sites. We all know how time-consuming it is to negotiate contracts and budget especially with big hospitals where the contacts goes from hands to hands to check it and find the most favorable conditions for either parties.   Polish legislator decided...

https://clinicalconsulting.pl/wp-content/uploads/2021/01/scott-graham-OQMZwNd3ThU-unsplash-1-1280x640.jpg

Regulation 536/2014 regarding the conduct of clinical trials will enter into force in 2019. It will be used directly in all European Union countries. Currently, there is a work under an act which is to regulate the areas that the EU legislator has left you to self-adapt and define for European countries.   However, the...

https://clinicalconsulting.pl/wp-content/uploads/2021/01/9fdfd7_12df8c5d9af34136981bae15c8221b58_mv2.png

Rare diseases, affect only or as much as 6 – 8% of humanity. They are very rare, but nonetheless exist and people suffer because of them. Orphan drugs – because this is the name of medicinal products used in rare diseases must have an orphan designation by submitting an application for Authorities.   The most...

HEADQUARTER

ul. Dzwonkowa 104

43-100 Tychy, Poland

+48 32 227 20 05

office@clinicalconsulting.pl

WARSAW OFFICE

Al. Jana Pawla II

27 00-867 Warszawa, Poland

+48 32 227 20 05

rental@clinicalconsulting.pl

©2020 Clinical Consulting. Privacy Policy. Website by: Black Wolf sp. z o. o.